{"chunk_id": "medquad__chunk_7027", "source": "medquad", "text": "on.     - A clinical trial of a new treatment.\n\t\t\t\t                \n\t\t\t\t                \n\t\t\t\t                    Refractory Gastrointestinal Stromal Tumors\n\t\t\t\t                    Many GISTs treated with a tyrosine kinase inhibitor (TKI) become refractory (stop responding) to the drug after a while. Treatment is usually a clinical trial with a different TKI or a clinical trial of a new drug.\n\t\t\t\t                \n\t\t\t\t                \n\t\t\t\t                    Treatment Options in Clinical Trials"}